Gts Securities »

Apellis Pharmaceuticals shares owned by Gts Securities

Quarter-by-quarter ownership of Apellis Pharmaceuticals (APLS) shares owned by Gts Securities from 13F filings

Historical chart of Gts Securities investment in Apellis Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Apellis Pharmaceuticals held by Gts Securities consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Apellis Pharmaceuticals by Gts Securities

Quarter filed Position value Share count Share price at filing
2023-12-31 $23M 391k 59.86
2023-09-30 $15M 394k 38.04
2023-06-30 $1.3M 14k 91.10

More positions owned by Gts Securities

Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
NVIDIA Corporation Put Option (NVDA)
Microsoft Corporation Put Option (MSFT)
Meta Platforms Cl A Put Option (META)
Tesla Motors Put Option (TSLA)
Amazon Put Option (AMZN)
Netflix Put Option (NFLX)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Apple Put Option (AAPL)
Alphabet Cap Stk Cl A Put Option (GOOGL)
Alphabet Cap Stk Cl C Put Option (GOOG)
Advanced Micro Devices Put Option (AMD)
Broadcom Put Option (AVGO)
Costco Wholesale Corporation Put Option (COST)

View all positions for Gts Securities

Top funds holding Apellis Pharmaceuticals

Wellington Management Company
EcoR1 Capital
venBio Select Advisor
Vanguard Group
Jennison Associates
Octagon Capital Advisors
Jpmorgan Chase & Co
T. Rowe Price Associates
Assenagon Asset Management
Logos Global Management
Boxer Capital
Artal Group
Citadel Advisors
Caption Management
Norges Bank Investment Management

View all funds holding Apellis Pharmaceuticals